Recordati launches hypertension drug in France
This new specialty Zanextra is already available in Germany, Australia, Ireland, Finland, Denmark, Greece, South Africa and in the Netherlands. Giovanni Recordati, chairman and CEO of Recordati, said:
Akeso has received approval from China’s National Medical Products Administration (NMPA) for gumokimab (AK111), an anti-Interleukin-17 (IL-17) monoclonal antibody, to treat adults with moderate-to-severe plaque psoriasis.